SDGR
Schrödinger, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong buy
+57/100
Last price
29.07
▼ 3.53 (10.83%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
32.68
Prev close
32.60
Day high
33.78
Day low
28.56
Volume
5.26M
Market cap
$2.16B
P/E (TTM)
—
52W range
10.95 – 33.78
Day trading desk
Gap from prior close
+0.25%
Prior close 32.60
VWAP
29.59
-1.74% from price
Relative volume
6.31×
Unusually busy
Session range
18.28%
28.56 – 33.78
Position in range
10%
Near session low
ATR (14D)
2.66
9.14% of price
Prior day high
33.09
PDH
Prior day low
29.56
PDL
Bid / ask spread
—
Quote not published
Session volume
10.24M
Avg 1.62M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.71%
-6.7%
1M
+43.85%
+42.7%
3M
+79.61%
+75.1%
6M
+153.73%
+135.5%
YTD
+61.63%
+47.4%
1Y
+40.36%
+23.9%
3Y
+2.23%
-80.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SDGR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+825.45K
Net buying
Buy transactions
12
944.77K shares
Sell transactions
4
119.32K shares
Net transactions
+16
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
2.25M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 17, 26 | AKINSANYA-AKIWUMI KAREN OLUFUNMILYO Officer |
CONVERSION | 31.60K | $137.14K | Direct |
| Sep 17, 26 | AKINSANYA-AKIWUMI KAREN OLUFUNMILYO Officer |
SELL | 31.60K | $927.97K | Direct |
| Jul 16, 26 | JAIN RACHIT Chief Financial Officer |
SELL | 875 | $13.65K | Direct |
| Jun 26, 26 | FRIESNER RICHARD A Director |
STOCK | 679.37K | $0 | Indirect |
| Jun 22, 26 | LYNTON MICHAEL M Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | GINSBERG GARY L Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | OBEROI ARUN Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | VAN KRALINGEN BRIDGET ANNE Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | CHODAKEWITZ JEFFREY A. M.D. Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | SENDER GARY L. Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | THORNBERRY NANCY A. Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | FRIESNER RICHARD A Director |
STOCK | 8.14K | $0 | Direct |
| Jun 22, 26 | KAPELLER-LIBERMANN ROSANA Director |
STOCK | 8.14K | $0 | Direct |
| Apr 17, 26 | RAMY SAMIR FARID PH.D. Chief Executive Officer |
CONVERSION | 160.53K | $492.82K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ABEL ROBERT LORNE |
Officer | 55.90K | Sale |
AKINSANYA-AKIWUMI KAREN OLUFUNMILYO |
Officer | 69.96K | Conversion of Exercise of derivative security |
AKLIAN MANNIX VARTAN |
Officer | 31.19K | Stock Award(Grant) |
FRIESNER RICHARD A |
Director | — | Stock Gift |
HERMAN JENNY |
Officer | 34.80K | Sale |
JAIN RACHIT |
Chief Financial Officer | 50.88K | Sale |
LORTON KENNETH PATRICK |
Officer | 89.24K | Sale |
PORGES GEOFFREY CRAIG |
Chief Financial Officer | 27.54K | Stock Award(Grant) |
RAMY SAMIR FARID PH.D. |
Chief Executive Officer | 405.35K | Conversion of Exercise of derivative security |
TRAN YVONNE KIM |
Officer | 52.68K | Sale |
Fundamentals
Market cap$2.16B
Enterprise value$1.86B
Revenue (TTM)$259.04M
Gross profit$147.31M
EBITDA$-147.58M
Net income$-54.34M
EPS (TTM)$-0.74
Free cash flow$-29.16M
Total cash$413.74M
Total debt$108.00M
Book value / share$4.51
Shares outstanding65.64M
Float57.33M
Short % of float26.61%
Dividend yield0.00%
Beta (5Y)1.62
Valuation & profitability ratios
Trailing P/E—
Forward P/E-21.41
PEG ratio—
Price / sales—
Price / book6.40
EV / revenue7.17
EV / EBITDA-12.58
Gross margin56.87%
Operating margin-70.55%
Profit margin-20.98%
Return on equity-16.17%
Return on assets-14.44%
Debt / equity32.83
Current ratio2.71
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $255.87M | $207.54M | $216.67M | $180.96M | — | +23.3% |
| Operating revenue | $255.87M | $207.54M | $216.67M | $180.96M | — | +23.3% |
| Cost of revenue | $113.25M | $75.46M | $75.97M | $79.93M | — | +50.1% |
| Gross profit | $142.61M | $132.08M | $140.69M | $101.02M | — | +8.0% |
| Research & development | $173.14M | $201.78M | $181.77M | $126.37M | — | -14.2% |
| Selling, general & admin | $136.37M | $139.59M | $136.37M | $121.47M | — | -2.3% |
| Total operating expense | $309.51M | $341.38M | $318.14M | $247.84M | — | -9.3% |
| Operating income | -$166.90M | -$209.30M | -$177.45M | -$146.82M | — | +20.3% |
| Net interest income | — | — | — | — | $1.06M | — |
| Pre-tax income | -$102.33M | -$185.71M | $42.92M | -$149.12M | — | +44.9% |
| Tax provision | $939.00K | $1.41M | $2.20M | $63.00K | — | -33.5% |
| Net income | -$103.27M | -$187.12M | $40.72M | -$149.19M | — | +44.8% |
| Net income to common | -$103.27M | -$187.12M | $40.72M | -$149.19M | — | +44.8% |
| Basic EPS | -1.41 | -2.57 | 0.57 | -2.10 | — | +45.1% |
| Diluted EPS | -1.41 | -2.57 | 0.54 | -2.10 | — | +45.1% |
| EBIT | -$166.90M | -$209.30M | -$177.45M | -$146.82M | — | +20.3% |
| EBITDA | -$160.87M | -$203.14M | -$171.90M | -$142.47M | — | +20.8% |
| Basic shares | 73.44M | 72.67M | 71.78M | 71.17M | — | +1.1% |
| Diluted shares | 73.44M | 72.67M | 74.99M | 71.17M | — | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $230.52M | $147.33M | $155.31M | $90.47M | +56.5% |
| Cash & short-term investments | $395.46M | $352.12M | $463.00M | $451.09M | +12.3% |
| Accounts receivable | $83.04M | $235.69M | $65.99M | $55.95M | -64.8% |
| Total current assets | $519.26M | $634.99M | $567.80M | $533.99M | -18.2% |
| Property, plant & equipment | $122.19M | $136.08M | $141.10M | $120.23M | -10.2% |
| Goodwill & intangibles | $4.79M | $4.79M | $4.79M | $5.38M | 0.0% |
| Total assets | $726.16M | $823.23M | $802.96M | $688.59M | -11.8% |
| Total current liabilities | $189.14M | $191.75M | $133.67M | $108.80M | -1.4% |
| Total debt | $109.23M | $117.83M | $127.88M | $116.49M | -7.3% |
| Total liabilities | $362.11M | $401.78M | $254.40M | $240.68M | -9.9% |
| Retained earnings | -$628.81M | -$525.54M | -$338.42M | -$379.14M | -19.6% |
| Shareholder equity | $364.05M | $421.44M | $548.56M | $447.89M | -13.6% |
| Working capital | $330.13M | $443.25M | $434.12M | $425.19M | -25.5% |
| Net tangible assets | $359.26M | $416.65M | $543.77M | $442.52M | -13.8% |
| Shares issued | 73.68M | 72.87M | 72.14M | 71.33M | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$103.27M | -$187.12M | $40.72M | -$149.19M | +44.8% |
| Depreciation & amortisation | $6.02M | $6.16M | $5.55M | $4.34M | -2.2% |
| Stock-based compensation | $43.00M | $49.90M | $47.84M | $39.63M | -13.8% |
| Change in working capital | $118.17M | -$13.04M | -$22.55M | -$21.38M | +1,006.2% |
| Operating cash flow | $13.90M | -$157.37M | -$136.73M | -$119.68M | +108.8% |
| Capital expenditure | -$1.44M | -$7.31M | -$13.40M | -$8.01M | +80.3% |
| Investing cash flow | $57.90M | $148.84M | $193.03M | $90.02M | -61.1% |
| Financing cash flow | $2.93M | $10.12M | $9.05M | $2.11M | -71.0% |
| Free cash flow | $12.46M | -$164.68M | -$150.14M | -$127.70M | +107.6% |
| End cash position | $237.38M | $162.66M | $161.07M | $95.72M | +45.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $58.89M | $58.59M | $87.23M | $54.32M | $54.76M | — | +0.5% |
| Operating revenue | $58.89M | $58.59M | $87.23M | $54.32M | $54.76M | — | +0.5% |
| Cost of revenue | $26.46M | $29.04M | $29.94M | $26.29M | $28.60M | — | -8.9% |
| Gross profit | $32.43M | $29.55M | $57.29M | $28.04M | $26.16M | — | +9.8% |
| Research & development | $41.00M | $43.82M | $41.40M | $42.76M | $43.14M | — | -6.4% |
| Selling, general & admin | $32.98M | $34.52M | $33.05M | $31.23M | $35.92M | — | -4.4% |
| Total operating expense | $73.98M | $78.34M | $74.45M | $73.99M | $79.06M | — | -5.6% |
| Operating income | -$41.55M | -$48.79M | -$17.16M | -$45.95M | -$52.90M | — | +14.9% |
| Pre-tax income | $7.35M | -$59.62M | $32.97M | -$32.63M | -$42.89M | — | +112.3% |
| Tax provision | $1.37M | $408.00K | $462.00K | $162.00K | $287.00K | — | +236.3% |
| Net income | $5.97M | -$60.03M | $32.51M | -$32.80M | -$43.17M | — | +110.0% |
| Net income to common | $5.97M | -$60.03M | $32.51M | -$32.80M | -$43.17M | — | +110.0% |
| Basic EPS | 0.08 | -0.81 | — | -0.45 | -0.59 | -0.82 | +109.9% |
| Diluted EPS | 0.08 | -0.81 | — | -0.45 | -0.59 | -0.82 | +109.9% |
| EBIT | -$41.55M | -$48.79M | -$17.16M | -$45.95M | -$52.90M | — | +14.9% |
| EBITDA | -$40.06M | -$47.32M | -$15.72M | -$44.48M | -$51.37M | — | +15.3% |
| Basic shares | 74.71M | 73.99M | — | 73.61M | 73.43M | 73.06M | +1.0% |
| Diluted shares | 75.77M | 73.99M | — | 73.61M | 73.43M | 73.06M | +2.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $287.85M | $260.25M | $230.52M | $172.12M | $219.90M | +10.6% |
| Cash & short-term investments | $413.74M | $398.96M | $395.46M | $391.23M | $450.19M | +3.7% |
| Accounts receivable | $21.39M | $27.25M | $83.04M | $29.38M | $10.07M | -21.5% |
| Total current assets | $470.48M | $463.96M | $519.26M | $471.72M | $514.00M | +1.4% |
| Property, plant & equipment | $120.37M | $120.64M | $122.19M | $125.84M | $129.06M | -0.2% |
| Goodwill & intangibles | $4.79M | $4.79M | $4.79M | $4.79M | $4.79M | 0.0% |
| Total assets | $640.39M | $634.19M | $726.16M | $653.66M | $688.24M | +1.0% |
| Total current liabilities | $173.84M | $169.54M | $189.14M | $145.11M | $155.77M | +2.5% |
| Total debt | $107.98M | $106.96M | $109.23M | $111.43M | $114.31M | +1.0% |
| Total liabilities | $311.44M | $320.64M | $362.11M | $332.31M | $345.37M | -2.9% |
| Retained earnings | -$682.86M | -$688.83M | -$628.81M | -$661.32M | -$628.52M | +0.9% |
| Shareholder equity | $328.96M | $313.55M | $364.05M | $321.35M | $342.87M | +4.9% |
| Working capital | $296.63M | $294.42M | $330.13M | $326.61M | $358.23M | +0.8% |
| Net tangible assets | $324.17M | $308.76M | $359.26M | $316.56M | $338.08M | +5.0% |
| Shares issued | 74.78M | 74.55M | 73.68M | 73.63M | 73.59M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.97M | -$60.03M | $32.51M | -$32.80M | -$43.17M | +110.0% |
| Depreciation & amortisation | $1.49M | $1.48M | $1.44M | $1.47M | $1.53M | +0.8% |
| Stock-based compensation | $8.79M | $9.07M | $9.95M | $10.85M | $10.63M | -3.1% |
| Change in working capital | -$4.90M | $21.81M | -$13.47M | -$31.03M | -$15.81M | -122.5% |
| Operating cash flow | -$34.07M | -$14.83M | -$16.09M | -$61.87M | -$52.20M | -129.7% |
| Capital expenditure | -$362.00K | -$2.51M | -$41.00K | -$491.00K | -$314.00K | +85.6% |
| Investing cash flow | $58.62M | $44.60M | $71.41M | $11.46M | -$55.60M | +31.4% |
| Financing cash flow | $650.00K | $569.00K | $197.00K | $307.00K | $2.02M | +14.2% |
| Free cash flow | -$34.43M | -$17.34M | -$16.13M | -$62.36M | -$52.51M | -98.6% |
| End cash position | $292.92M | $267.72M | $237.38M | $181.87M | $231.98M | +9.4% |
Options analytics
Put / call volume
0.19
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
12.50
-56.7% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
5.30K
Contracts, this expiry
Put volume
985
Contracts, this expiry
Heaviest call OI
17.50
0 contracts
Heaviest put OI
12.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.67 | -0.42 | +37.9% |
| Mar 2026 | -0.57 | -0.62 | -8.9% |
| Dec 2025 | -0.09 | -0.18 | -100.2% |
| Sep 2025 | -0.74 | -0.57 | +23.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.52 | 1 | $48.55M | -10.6% |
| Next quarter | -0.16 | 1 | $74.68M | -14.4% |
| Current year | -1.83 | 1 | $242.72M | -5.1% |
| Next year | -1.35 | 1 | $250.30M | +3.1% |
Analyst targets & ownership
Mean target$21.43
High target$30.00
Low target$17.00
Implied upside-26.29%
Analyst count7
ConsensusNONE
Strong buy / Buy0 / 5
Hold2
Sell / Strong sell0 / 0
Held by insiders3.00%
Held by institutions97.00%
Institutions holding324
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
30.07
-3.32% from price
SMA 20
27.29
+5.89% from price
SMA 50
21.93
+31.76% from price
SMA 100
18.47
+57.36% from price
SMA 200
16.09
+79.56% from price
EMA 12
29.35
-0.94% from price
EMA 26
26.61
+9.25% from price
EMA 50
23.44
+24.01% from price
RSI (14)
58.1
Neutral
MACD (12,26,9)
2.74
Hist -0.08
ATR (14)
2.66
9.19% of price
Realised vol 30D
98.1%
Annualised
Bollinger upper
36.21
20, 2σ
Bollinger lower
18.38
20, 2σ
50 / 200 cross
Golden
21.93 vs 16.09
Trend bias
Above 200
+79.56%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.64
More volatile than market
Correlation to SPY
0.34
Loosely linked
Realised vol 30D
98.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-50.8%
Peak to trough
Max drawdown 5Y
-81.3%
Peak to trough
ATR 14
2.66
9.19% of price
Beta (reported)
1.62
5Y monthly, from filing
Short interest
Shares short
11.17M
Prior 11.43M
Change vs prior
-2.3%
Shorts covering
% of float
26.61%
Heavily shorted
% of shares out
14.93%
Against total outstanding
Days to cover
10.0
Crowded exit
Float
57.33M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 14, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 8, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Mar 17, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jan 8, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jan 8, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jan 7, 26 | UBS | INITIATED | — | Neutral |
| Dec 15, 25 | B of A Securities | UPGRADE | Neutral | Buy |
| Oct 8, 25 | Keybanc | MAINTAINED | Overweight | Overweight |
| Sep 30, 25 | Goldman Sachs | INITIATED | — | Neutral |
| Aug 18, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 15, 25 | Citigroup | DOWNGRADE | Buy | Neutral |
| Aug 14, 25 | Barclays | INITIATED | — | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-29
Corporate Changes & Voting Matters
8-K · 2026-06-23
Corporate Changes & Voting Matters
8-K · 2026-06-08
Corporate Changes & Voting Matters
8-K · 2026-05-20
Periodic Financial Reports
10-Q · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-03-12
Headlines
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Zacks · 20h ago
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View
Simply Wall St. · 9d ago
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
Zacks · 13d ago
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
Barchart · 14d ago
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing
MT Newswires · 15d ago
Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
Barchart · 18d ago
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
Zacks · 19d ago
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.